https://news.bloomberglaw.com/securities-law/mesoblast-hit-with-investor-suit-over-fda-clinical-study-request
Did not finish earlier post
I started having doubts after criticism of the potency measurement issue by the committee as it seemed so fundamental one would assume it would have been covered in full. Then there were recent comments about the early failed trial . Given the CEO and others have been dripping with wealth on the company professing excellence I hope the company can pushback but this does not look good . The slightest hint of lack of complete full disclosure regarding methodology, results and equivalent comparisons will be disastrous.
IRENE KRISTAL, I, Plaintiff, v. MESOBLAST LIMITED, SILVIU ITESCU, and JOSH MUNTNER, Defendants., page-142
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |